Olivier Laureau: Why Patient Voices Matter in Therapeutic Innovation
Olivier Laureau/LinkedIn

Olivier Laureau: Why Patient Voices Matter in Therapeutic Innovation

Olivier Laureau, President at Servier Foundation and Servier Group, shared on LinkedIn:

“One of the most meaningful moments of my last visit to Japan was meeting Laureline Gatellier, a representative of an important Japanese patient group in oncology.

Her testimony was both humbling and inspiring.

Because living with cancer is about uncertainty, resilience and hope.

It highlighted how innovation is not only about scientific progress, but also about the difference it makes in people’s lives.

As leaders, pharma teams, healthcare professionals and industry partners, we are committed to advancing innovation, always keeping in mind that patients are the beneficiaries of everything we do.

They inspire us.

At Servier, we innovate to advance therapeutic progress for the benefit of patients.

Thank you, Laureline, for this meaningful conversation and your trust.”

You can also read: Solidarity as a Collective Movement for Social Impact – Servier

Olivier Laureau: Why Patient Voices Matter in Therapeutic Innovation